Free Trial

Nuvectis Pharma (NVCT) Insider Trading & Ownership

Nuvectis Pharma logo
$10.43 -0.63 (-5.70%)
As of 12:00 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Nuvectis Pharma (NASDAQ:NVCT) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
30.52%
Number Of
Insiders Buying
(Last 12 Months)
4
Amount Of
Insider Buying
(Last 12 Months)
$1.61M
Number Of
Insiders Selling
(Last 12 Months)
0
Get NVCT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Nuvectis Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NVCT Insider Buying and Selling by Quarter

Nuvectis Pharma Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/5/2025
Juan Sanchez
Juan Sanchez
Director
Buy13,000$5.79$75,270.00  
11/5/2025
Matthew L Kaplan
Director
Buy11,000$5.84$64,240.00  
11/5/2025
Ron Bentsur
CEO
Buy5,000$5.72$28,600.00  
10/27/2025
Marlio Charles Mosseri
Major Shareholder
Buy72,836$6.28$457,410.08  
10/24/2025
Marlio Charles Mosseri
Major Shareholder
Buy35,034$6.15$215,459.10  
10/23/2025
Marlio Charles Mosseri
Major Shareholder
Buy46,900$6.06$284,214.00  
6/20/2025
Marlio Charles Mosseri
Major Shareholder
Buy5,603$7.99$44,767.97  
6/18/2025
Marlio Charles Mosseri
Major Shareholder
Buy28,043$8.05$225,746.15  
6/17/2025
Marlio Charles Mosseri
Major Shareholder
Buy5,399$8.11$43,785.89  
5/12/2025
Marlio Charles Mosseri
Major Shareholder
Buy21,167$8.11$171,664.37  
(Data available from 1/1/2013 forward)

NVCT Insider Trading Activity - Frequently Asked Questions

The list of insiders at Nuvectis Pharma includes Enrique Poradosu, Juan Sanchez, Marlio Charles Mosseri, Matthew L Kaplan, and Ron Bentsur. Learn more on insiders at NVCT.

30.52% of Nuvectis Pharma stock is owned by insiders. Learn more on NVCT's insider holdings.

The following insiders have purchased NVCT shares in the last 24 months: Enrique Poradosu ($9,980.00), Juan Sanchez ($75,270.00), Marlio Charles Mosseri ($2,852,764.02), Matthew L Kaplan ($64,240.00), and Ron Bentsur ($161,000.60).

Insiders have purchased a total of 544,516 NVCT shares in the last 24 months for a total of $3,163,254.62 bought.



This page (NASDAQ:NVCT) was last updated on 5/12/2026 by MarketBeat.com Staff.
From Our Partners